Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial
Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added. The older Revision: v3.4.1 notice and the funding-status alert were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedA new data field 'Last Update Submitted that Met QC Criteria' was added to the study record, and the page revision is shown as v3.4.0. The page also adds a 'Show glossary' option and makes minor capitalization adjustments for FEAR Act data and QC-related labels.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now displays a Locations section with participating sites by state and includes a new revision tag to v3.3.3.SummaryDifference2%

- Check92 days agoChange DetectedRevision metadata updated from v3.2.0 to v3.3.2 at the bottom of the page.SummaryDifference0.0%

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.